Hanudel, Mark R.
Laster, Marciana L.
Portale, Anthony A.
Dokras, Aditi
Quigley, Raymond P.
Guzman, German A. Lozano
Zaritsky, Joshua J.
Hayde, Nicole A.
Kaskel, Frederick J.
Mitsnefes, Mark M.
Ramirez, Jorge A.
Imani, Peace D.
Srivaths, Poyyapakkam R.
Kogon, Amy J.
Denburg, Michelle R.
Blydt-Hansen, Tom D.
Reyes, Loretta Z.
Greenbaum, Larry A.
Weidemann, Darcy K.
Warady, Bradley A.
Elashoff, David A.
Mendley, Susan R.
Isakova, Tamara
Salusky, Isidro B. http://orcid.org/0000-0001-8052-416X
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK122013, K23-DK123378)
Article History
Received: 24 November 2021
Revised: 31 January 2022
Accepted: 1 February 2022
First Online: 2 March 2022
Declarations
:
: MRH has received research funding from Akebia Therapeutics, Inc. BAW and IBS are consultants for Akebia Therapeutics, Inc.